Evidence map›Paper›PMID 41936431›Full record

ReviewEndocrine journal2026

Emerging human cell-based in vitro models for studying pituitary development and disorders.

Ryusaku Matsumoto, Ayaka Nishio, Yutaka Takahashi, Takuya Yamamoto

Abstract readReview
In one paragraph

Review in Endocrine journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ryusaku MatsumotoCenter for iPS Cell Research and Application, Kyoto University, Kyoto 606-8507, Japan.ORCID http://orcid.org/0000-0002-7191-5326
Ayaka NishioCenter for iPS Cell Research and Application, Kyoto University, Kyoto 606-8507, Japan.
Yutaka TakahashiDepartment of Diabetes and Endocrinology, Nara Medical University, Nara 634-8522, Japan.
Takuya YamamotoCenter for iPS Cell Research and Application, Kyoto University, Kyoto 606-8507, Japan.ORCID http://orcid.org/0000-0002-0022-3947

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pituitary gland plays a central role in maintaining physiological homeostasis by secreting multiple hormones that regulate diverse body functions. Dysregulation of pituitary hormones can arise from various conditions, such as pituitary tumors and autoimmune diseases, leading to a broad spectrum of symptoms. During embryonic organogenesis, the pituitary gland originates from the oral ectoderm in close contact with the adjacent hypothalamus. This tissue interaction is essential for proper development. Although the molecular mechanisms underlying pituitary development and related disorders have been extensively studied using animal models, such as rodents and zebrafish, species-specific differences limit the translatability of these findings to humans. Moreover, the scarcity of established human pituitary cell lines has hindered the investigation of human-specific mechanisms. Recent biotechnological advances have addressed these limitations by enabling the long-term culture of human pituitary tumor tissues and in vitro generation of pituitary hormone-producing cells from human pluripotent stem cells. These emerging platforms provide powerful tools for deepening our understanding of pituitary biology and diseases. In this review, we summarize current in vitro experimental models derived from pituitary tissues and pluripotent stem cells and discussed their applications in the study of pituitary development, physiology, and related disorders.

Indexed as

Pituitary DiseasesPituitary GlandPluripotent Stem CellsAnimalsHumansModels, BiologicalPituitary NeoplasmsHuman induced pluripotent stem cellsHuman pluripotent stem cellsOrganoidPituitaryPituitary tumor

Identifiers

PMID41936431
PMCPMC13378847

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.